In this edition:

–  Remote pulmonary artery pressure monitoring in chronic HF
–  CTS associated with subsequent HF
–  RAS inhibition and outcomes in HFREF and advanced kidney disease
–  CRP and incident HF risk in patients with CV disease
–  LBBAP vs. BVP in CRT candidates
–  Torsemide vs. furosemide in hospitalised HF: symptoms and QOL
–  Anaemia: effect of sacubitril-valsartan
–  Neurohormonal antagonist initiation after HF hospitalisation in older adults
–  Predictors of long-term CV and non-CV mortality in HFPEF
–  HF pharmacotherapies and outcomes in obese vs. nonobese HFREF patients

Download the Heart Failure Research Review: Issue 79, with commentary by Prof Andrew Coats (pdf)